Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Alfapump Cohort Study: in Patients With Refractory Ascites Due to Liver Cirrhosis or Malignant Ascites With a Life Expectancy of 6 Months or Less

NCT04326946 is registered in ClinicalTrials.gov with Sequana Medical N.V. as lead sponsor.

NCT NCT04326946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04326946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Alfapump Cohort Study: in Patients With Refractory Ascites Due to Liver Cirrhosis or Malignant Ascites With a Life Expectancy of 6 Months or Less
Lead sponsor
Sequana Medical N.V.
Phase
Observational
Overall status
Active, not recruiting
Start date
August 14, 2018
Completion date
December 31, 2030
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhoses, malignant ascites